stay updated with our newsletter

Sugar Changes the Microbiome & Fuels Metabolic Disease

A new mice study in the journal Cell helps explain how a high-sugar, high-fat Western-style diet disrupts the gut microbiome, increasing the risk of metabolic disease, pre-diabetes, and weight gain. Study Details Researchers from Columbia University Vagelos College of Physicians and Surgeons set out to investigate the impact of theRead

Link Between Artificial Sweeteners and Diabetes

Pink, yellow, or blue? Each of these non-caloric sweeteners may be contributing to the global epidemic of diabetes. The study published in Nature today (Sept. 17, 2014), shows the non-nutritive sweeteners, saccharin, sucralose and aspartame, could actually hasten the development of glucose intolerance and metabolic disease. The mechanism is surprising: these no-calorie sweeteners change the composition and function of gut microbiota. The researchers found the results so compelling they went so far as to call for a reassessment of non-nutritive sweeteners. By Eran Segal, Eran Elinav, published in Nature, Sept. 17, 2014.

Hispanic Men Most Affected by Diabetes Epidemic

Close to half (40%) of the adult population of the USA is expected to develop type 2 diabetes at some point during their lifetime, suggests a major study published in The Lancet Diabetes & Endocrinology. The future looks even worse for some ethnic minority groups, with one in two (> 50%) Hispanic men and women and non-Hispanic black women predicted to develop the disease. A team of US researchers combined data from nationally representative US population interviews and death certificates for about 600 000 adults to estimate trends in the lifetime risk of diabetes and years of life lost to diabetes in the USA between 1985 and 2011.

Integrating Diet and Physical Activity in Type-2 Diabetes Therapy to Reduce Inflammation

inflammation
As studies show, inflammation plays a major role in diabetes-associated cardiovascular disease (CVD). Yet, many clinics are reluctant to integrate diet and physical activity interventions into healthcare settings and reduce markers of inflammation and risk of CVD in patients with type 2 diabetes (T2D). This study examined the systemic markers

Read more

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.